Compromised insulin action and/or insulin secretion contribute to the setting and maintaining conditions such as hyperglycemia, hyperlipidemia, hypertension, and obesity, all of which are standard features of MS [21]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.